Financial results - GRANDPHARMA SRL

Financial Summary - Grandpharma Srl
Unique identification code: 25871000
Registration number: J40/8684/2009
Nace: 4690
Sales - Ron
-
Net Profit - Ron
-1.837
Employees
Open Account
Company Grandpharma Srl with Fiscal Code 25871000 recorded a turnover of 2024 of - , with a net profit of -1.837 and having an average number of employees of - . The company operates in the field of Comerţ cu ridicata nespecializat having the NACE code 4690.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Grandpharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 34.236 106.279 1.330.074 1.434.407 1.012.109 129.448 109.066 134 0 0
Total Income - EUR 34.828 112.720 1.334.966 1.445.831 1.021.933 139.755 118.160 135 0 0
Total Expenses - EUR 115.942 101.644 1.242.209 1.288.276 868.680 130.472 115.612 4.178 4.784 1.837
Gross Profit/Loss - EUR -81.115 11.076 92.757 157.555 153.253 9.283 2.548 -4.043 -4.784 -1.837
Net Profit/Loss - EUR -81.115 11.076 77.979 130.621 131.339 7.101 -502 -4.047 -4.784 -1.837
Employees 1 1 2 2 2 2 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Grandpharma Srl

Rating financiar

Financial Rating -
GRANDPHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Grandpharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Grandpharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Grandpharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Grandpharma Srl - CUI 25871000

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 34.485 17.828 11.905 66.461 26.420 14.203 2.377 1.425 465 0
Current Assets 26.749 42.397 83.739 179.597 242.882 29.716 9.652 3.909 1.159 1.133
Inventories 15.590 17.415 8.702 168.320 80.220 19.358 0 0 0 0
Receivables 8.703 20.204 1.411 3.215 13.621 1.683 118 463 1.112 1.133
Cash 2.456 4.777 73.626 8.061 149.041 8.675 9.534 3.447 48 0
Shareholders Funds -13.847 -2.630 75.393 130.673 259.482 38.607 9.352 5.333 533 -1.307
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 75.081 62.855 20.250 115.385 9.820 5.312 2.676 0 1.091 2.440
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4690 - 4690"
CAEN Financial Year 4690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.133 euro in 2024 which includes Inventories of 0 euro, Receivables of 1.133 euro and cash availability of 0 euro.
The company's Equity was valued at -1.307 euro, while total Liabilities amounted to 2.440 euro. Equity decreased by -1.837 euro, from 533 euro in 2023, to -1.307 in 2024.

Risk Reports Prices

Reviews - Grandpharma Srl

Comments - Grandpharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.